Unió Europea -
danès -
EMA (European Medicines Agency)
tecfidera
biogen netherlands b.v. - dimethylfumarat - multipel sclerose - immunosuppressiva - tecfidera is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).
Dinamarca -
danès -
Lægemiddelstyrelsen (Danish Medicines Agency)
denise 150+20 mikrogram tabletter
teva b.v. - desogestrel, ethinylestradiol - tabletter - 150+20 mikrogram
Dinamarca -
danès -
Lægemiddelstyrelsen (Danish Medicines Agency)
gestodilat 75+20 mikrogram overtrukne tabletter
teva b.v. - ethinylestradiol, gestoden - overtrukne tabletter - 75+20 mikrogram
Dinamarca -
danès -
Lægemiddelstyrelsen (Danish Medicines Agency)
gestodilat 75+30 mikrogram overtrukne tabletter
teva b.v. - ethinylestradiol, gestoden - overtrukne tabletter - 75+30 mikrogram
Dinamarca -
danès -
Lægemiddelstyrelsen (Danish Medicines Agency)
denise 150+30 mikrogram tabletter
2care4 aps - desogestrel, ethinylestradiol - tabletter - 150+30 mikrogram
Unió Europea -
danès -
EMA (European Medicines Agency)
vumerity
biogen netherlands b.v. - diroximel fumarate (biib098) - multipel sklerose, recidiverende-remitterende - immunosuppressiva - vumerity is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (see section 5. 1 for important information on the populations for which efficacy has been established).
Unió Europea -
danès -
EMA (European Medicines Agency)
dimethyl fumarate polpharma
zaklady farmafarmaceutyczne polpharma s.aceutyczne polpharma s.a. - dimethylfumarat - multipel sklerose, recidiverende-remitterende - immunosuppressiva - dimethyl fumarate polpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
Unió Europea -
danès -
EMA (European Medicines Agency)
dimethyl fumarate teva
teva gmbh - dimethylfumarat - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunosuppressiva - dimethyl fumarate teva is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).
Unió Europea -
danès -
EMA (European Medicines Agency)
dimethyl fumarate accord
accord healthcare s.l.u. - dimethylfumarat - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunosuppressiva - dimethyl fumarate accord is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).
Dinamarca -
danès -
Lægemiddelstyrelsen (Danish Medicines Agency)
dimethyl fumarate "glenmark" 120 mg enterokapsler, hårde
glenmark arzneimittel gmbh - dimethylfumarat - enterokapsler, hårde - 120 mg